Asparlas® (calaspargase pegol-mknl)
for Leukemia

Asparlas (calaspargase pegol-mknl) treats acute lymphoblastic leukemia (ALL), a type of white blood cell cancer, in children and young adults (ages 1 month to 21 years). Used alongside other cancer medicines, it works by depriving cancer cells of essential nutrients, thereby slowing or stopping tumor growth.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Leukemia